Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Boston MA
Sponsor: Victor Wang
Sex: All
Age: 19+
Code: NCT06564233
Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
for
Estrogen-receptor-positive Breast Cancer,
Location: Boston MA
Sponsor: Kristina A. Fanucci
Sex: All
Age: 18+
Code: NCT07222215
Phase 2, Recruiting
Yoga for Persistent Post-Surgical Pain (PPSP)
for
Persistent Post-surgical Pain
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT06949007
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Boston MA, Lake Success NY, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase 2, Recruiting
Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
for
Gout Arthritis, Gout Flare, Gout
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70+
Code: NCT07346079
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
for
Cancer Predisposition Syndrome, Predisposition, Genetic
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 22+
Code: NCT06450171
Recruiting
PH 2 Pemigatinib in SDH-deficient GIST
for
SDH Gene Mutation, Gastrointestinal Stromal Tumor
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07434843
Phase 2, Recruiting
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Boston MA, The Bronx NY, Sherbrooke, Montreal, Toronto,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07225569
Phase 2, Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study